Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte that is essential for nerve and muscle function, particularly the heart. It is used to prevent or treat hypokalemia. Available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium supplementation during diuretic therapy. * Potassium replacement in conditions causing significant potassium loss (e.g., vomiting, diarrhea, hyperaldosteronism). ## Adult Dosing * **Oral:** * **Prevention:** 20 mEq (1.5 g) once daily or twice daily. * **Treatment:** 40-100 mEq (3 g - 7.5 g) per day, divided into 2-5 doses. Maximum daily dose typically 200 mEq (15 g), but may vary based on clinical indication and monitoring. * **Intravenous (IV):** * **Treatment of Hypokalemia:** Dosing is highly individualized based on serum potassium level, severity of symptoms, and rate of correction desired. Commonly initiated at 20-40 mEq (1.5 g - 3 g) per day, not to exceed 10 mEq/hour (0.75 g/hour) in a peripheral line or 20 mEq/hour (1.5 g/hour) in a central line, and not to exceed a total daily dose of 200 mEq (15 g). * **Concentration:** Peripheral IV: Do not exceed 40 mEq/L (3 g/L). Central IV: May be infused up to 100 mEq/L (7.5 g/L), but higher concentrations increase the risk of phlebitis and cardiac arrhythmias. * *Note: IV potassium administration rates and concentrations are critical and should follow institutional protocols and specific guidelines to prevent life-threatening arrhythmias.* ## Pediatric Dosing * **Oral:** * Recommended daily intake varies by age. For treatment of hypokalemia, doses are typically calculated based on body weight or surface area and serum potassium levels, often ranging from 1-5 mEq/kg/day (0.075 g - 0.375 g/kg/day), divided into doses. Maximum daily dose generally not to exceed 100 mEq (7.5 g). * **Intravenous (IV):** * Similar to adults, dosing is based on serum potassium levels and clinical condition. Commonly infused at rates of 0.3-1 mEq/kg/hour (0.022 g - 0.075 g/kg/hour), not to exceed 20 mEq/hour (1.5 g/hour). Maximum daily dose generally 3-4 mEq/kg/day (0.22 g - 0.3 g/kg/day), up to a maximum of 100 mEq (7.5 g) per day. * *Note: Concentration limits for pediatric IV infusions are crucial and typically lower than for adults to minimize risks.* ## Dose Adjustments * **Renal Impairment:** Use with extreme caution and significantly reduced doses. Monitor potassium levels closely. In severe renal impairment, potassium supplementation may be contraindicated. ## Contraindications * Hyperkalemia. * Conditions leading to elevated potassium levels (e.g., severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue breakdown). * Certain medications that can increase potassium (see drug interactions). ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence. * **Serious:** * **Hyperkalemia:** Weakness, fatigue, paresthesias, confusion, arrhythmias, cardiac arrest. Risk increases with renal impairment, rapid administration, high doses, and concomitant use of potassium-sparing drugs. * **Gastrointestinal:** Esophageal or gastric irritation/perforation (especially with oral solid dosage forms if not taken with sufficient fluid or if there is esophageal motility disorder). * **Cardiovascular:** Hypotension, arrhythmias (especially with rapid IV infusion). * **Vein Irritation:** With IV administration. ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE Inhibitors (e.g., lisinopril, enalapril), Angiotensin Receptor Blockers (ARBs) (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **NSAIDs (e.g., ibuprofen, naproxen):** May reduce potassium excretion, increasing risk of hyperkalemia. * **Heparin:** May increase potassium levels by impairing renal excretion. * **Digoxin:** High potassium levels can decrease the efficacy of digoxin. Low potassium levels can increase digoxin toxicity. * **Corticosteroids:** May increase potassium loss. ## Monitoring * **Serum Potassium:** Frequent monitoring is essential, especially during initiation of therapy, dose changes, and in patients with renal impairment or risk factors for hyperkalemia. Frequency depends on clinical status but can range from daily to weekly. * **Renal Function:** Monitor BUN and creatinine. * **ECG:** In patients receiving IV potassium, especially with rapid infusion or high doses, to assess for signs of hyperkalemia (e.g., peaked T waves, prolonged PR interval). * **Signs and Symptoms of Hypokalemia/Hyperkalemia:** Monitor for clinical manifestations. ## Clinical Pearls * Oral potassium chloride should always be taken with a large glass of water or juice to minimize gastrointestinal irritation and facilitate passage. * Liquid formulations may be better tolerated than solid dosage forms. * Never administer IV potassium push or as a bolus dose; it must be diluted and infused at a controlled rate. * Correcting severe hypokalemia too rapidly can be dangerous. * Consider underlying causes of hypokalemia (e.g., diuretic use, GI losses) for appropriate management. *** **Disclaimer:** This information is intended for clinical professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and institutional guidelines before administering any medication.